blog.aids.gov − HIV Vaccine
AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV - Changing to HIV.gov in Spring 2017

MENU

HIV Vaccine

NIH’s Dr. Carl Dieffenbach Discusses HIV Treatment Science at 2016 Ryan White Conference

Facebook Live with Carl Dieffenbach

As the 2016 National Ryan White Conference on HIV Care and Treatment wound down in Washington, DC, NIH’s Dr. Carl Dieffenbach and his colleague Anne Rancourt joined us for a conversation on Facebook Live about HIV treatment. They discussed what scientists now know about the benefits of HIV treatment and when people diagnosed with HIV…

HIV Vaccine Research: Update from NIH’s Dr. Dieffenbach from 2nd Day of AIDS 2016

Carl day 2 FB Live resized

As the second day of the International AIDS Conference (AIDS 2016) came to a close in Durban, South Africa, we caught up with Dr. Carl Dieffenbach again via Facebook Live to get his thoughts on some of the day’s highlights. He is Director of the Division of AIDS at NIH’s National Institute of Allergy and…

NIH Statement on HIV Vaccine Awareness Day

HIV Vaccine Day 2016 - Fauci quote - cropped May2016

Advances in HIV/AIDS research have given us the opportunity to transform the lives of those living with HIV while providing highly effective methods of preventing the infection. This progress has strengthened optimism for achieving a durable end to the HIV/AIDS pandemic. With an estimated two million new HIV infections occurring worldwide annually, however, controlling and…

HIV Vaccine and Cure Research Highlights from IAS 2015

"8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015).
Vancouver, Canada.
Copyright: Marcus Rose/IAS
Image Shows: (WEPL01) Co-chair: Quarraisha Abdool Karim, Centre for the AIDS Programme of Research in South Africa, South Africa"

As the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) came to a close in Vancouver, Canada, we spoke one last time by Skype with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), to learn about some of the…

NIH’s Dr. Carl Dieffenbach Shares Highlights as IAS 2015 Begins

IAS2015 logo crop2

After the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) got underway in Vancouver, Canada yesterday, July 20, we spoke by Skype with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID). He shared some highlights from the first full…

BULLETIN: HIV Vaccine Awareness Day 2015

nih logo

May 18, 2015 Vaccination has historically been the best method for protecting against and ultimately defeating mankind’s most devastating infectious diseases. Although the path to developing a safe and effective HIV vaccine has so far been difficult, achieving this goal remains key to realizing a durable end to the global HIV/AIDS pandemic. HIV vaccine development…

Statement from Ambassador Deborah L. Birx, M.D., U.S. Global AIDS Coordinator & U.S. Special Representative for Global Health Diplomacy, on HIV Vaccine Awareness Day

pepfar-HVAD-image_square

Editor’s Note: The following statement was released on Friday, May 15 by Ambassador Deborah L. Birx, The United States President’s Emergency Plan for AIDS Relief (PEPFAR) to commemorate today’s observance of HIV Vaccine Awareness Day. May 15, 2015 With no current cure for HIV/AIDS, an HIV vaccine could be a game changer in our effort…

Puerto Rico Makes Important Strides To Support Vaccine Research to Combat HIV

pr

The Obama Administration is a strong partner in helping Puerto Rico to develop the industries that will support its long-term economic growth. One such opportunity is to work through the President’s Task Force on Puerto Rico to identify opportunities can work more closely with partners to ensure that Puerto Rico’s best days are ahead. Earlier…